LEIDOS FUNDING TO25, OPTION 6 RCT RESPIRATORY VIRUS

Leidos 资助 TO25，选项 6 RCT 呼吸道病毒

• 批准号: 10935434
• 负责人: ETHAN DMITROVSKY
• 金额: $ 1723.74万
• 依托单位: LEIDOS BIOMEDICAL RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-28 至 2028-08-17
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10935434
• 关键词: Biology; Blinded; Cause of Death; Communicable Diseases; Coronavirus; Data; Disease; Emerging Communicable Diseases; Funding; Human; Incidence; Infectious Agent; Medical; Medical Research; Pathogenesis; Patient-Focused Outcomes; Protocols documentation; Publishing; Randomized; Safety; Therapeutic; acute infection; clinical investigation; improved; innovation; pathogen; previous outbreak; respiratory virus

Infectious diseases remain one of the leading causes of death worldwide despite innovations in medical research and the availability of new treatments. Emerging diseases include outbreaks of previously unknown diseases or known diseases where the incidence in humans has significantly increased in the past two decades. Detailed studies on emerging and re-emerging infectious agents to better understand pathogens’ biology and host pathogenesis are mostly lacking. The initial study protocol under this Task Order is to prepare for a rapid coordinated clinical investigation of acute infections of emerging and re-emerging infectious agents

尽管医学研究不断创新，新的治疗方法层出不穷，但传染病仍然是全球主要的死亡原因之一。新出现的疾病包括过去未知疾病或已知疾病的爆发，在过去二十年中，人类的发病率显著增加。对新出现和重新出现的传染性病原体的详细研究，以更好地了解病原体的生物学和宿主发病机制，大多缺乏。本任务指令下的初始研究方案旨在为新出现和再出现传染性病原体的急性感染的快速协调临床研究做准备